DK1031575T3 - Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler - Google Patents

Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler

Info

Publication number
DK1031575T3
DK1031575T3 DK00301526T DK00301526T DK1031575T3 DK 1031575 T3 DK1031575 T3 DK 1031575T3 DK 00301526 T DK00301526 T DK 00301526T DK 00301526 T DK00301526 T DK 00301526T DK 1031575 T3 DK1031575 T3 DK 1031575T3
Authority
DK
Denmark
Prior art keywords
preparation
growth hormone
hormone secretion
inducers
secretion inducers
Prior art date
Application number
DK00301526T
Other languages
Danish (da)
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1031575T3 publication Critical patent/DK1031575T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK00301526T 1999-02-26 2000-02-25 Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler DK1031575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26
EP00301526A EP1031575B1 (en) 1999-02-26 2000-02-25 Process for preparing growth hormone secretagogues

Publications (1)

Publication Number Publication Date
DK1031575T3 true DK1031575T3 (da) 2005-01-03

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00301526T DK1031575T3 (da) 1999-02-26 2000-02-25 Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler

Country Status (44)

Country Link
US (2) US6541634B2 (ja)
EP (2) EP1031575B1 (ja)
JP (3) JP3437813B2 (ja)
KR (2) KR100372063B1 (ja)
CN (3) CN1515570A (ja)
AP (1) AP1221A (ja)
AR (2) AR029617A1 (ja)
AT (1) ATE277944T1 (ja)
AU (1) AU764122B2 (ja)
BG (1) BG104175A (ja)
BR (2) BRPI0000967B8 (ja)
CA (1) CA2299495C (ja)
CO (1) CO5160252A1 (ja)
DE (1) DE60014212T2 (ja)
DK (1) DK1031575T3 (ja)
DZ (1) DZ3018A1 (ja)
EA (1) EA003218B1 (ja)
EE (1) EE200000193A (ja)
ES (1) ES2226712T3 (ja)
GT (1) GT200000018A (ja)
HK (1) HK1030219A1 (ja)
HN (1) HN2000000021A (ja)
HR (1) HRP20000103A2 (ja)
HU (1) HUP0000907A3 (ja)
ID (1) ID24861A (ja)
IL (2) IL157103A (ja)
IN (1) IN192352B (ja)
IS (1) IS5380A (ja)
MA (1) MA25072A1 (ja)
NO (1) NO20000965L (ja)
NZ (1) NZ503062A (ja)
OA (1) OA11325A (ja)
PA (1) PA8491201A1 (ja)
PE (1) PE20001550A1 (ja)
PL (1) PL338628A1 (ja)
PT (1) PT1031575E (ja)
SG (1) SG90096A1 (ja)
SI (1) SI1031575T1 (ja)
SK (1) SK284982B6 (ja)
TN (1) TNSN00035A1 (ja)
TR (1) TR200000536A2 (ja)
TW (2) TW200718702A (ja)
UA (1) UA70306C2 (ja)
ZA (1) ZA200000888B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
AU2001264977B2 (en) 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
TWI629982B (zh) 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 多晶型形式
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
AU1172995A (en) 1993-11-09 1995-05-29 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体

Also Published As

Publication number Publication date
AU1947100A (en) 2000-08-31
HUP0000907A3 (en) 2001-05-28
EA003218B1 (ru) 2003-02-27
HUP0000907A2 (en) 2001-03-28
HN2000000021A (es) 2001-02-02
ID24861A (id) 2000-08-31
JP2003261565A (ja) 2003-09-19
PT1031575E (pt) 2004-11-30
CN1515570A (zh) 2004-07-28
BRPI0000967B8 (pt) 2021-12-07
IL134599A (en) 2006-12-10
HRP20000103A2 (en) 2001-04-30
NO20000965D0 (no) 2000-02-25
TW200718702A (en) 2007-05-16
ATE277944T1 (de) 2004-10-15
AR029617A1 (es) 2003-07-10
GT200000018A (es) 2001-08-16
IL157103A (en) 2007-07-24
EA200000172A2 (ru) 2000-08-28
DE60014212T2 (de) 2005-12-15
EP1449842A1 (en) 2004-08-25
SK284982B6 (sk) 2006-03-02
OA11325A (en) 2003-10-27
BRPI0017522B1 (pt) 2013-09-24
PL338628A1 (en) 2000-08-28
JP3437813B2 (ja) 2003-08-18
BRPI0000967B1 (pt) 2012-06-12
PA8491201A1 (es) 2001-04-30
US20020002283A1 (en) 2002-01-03
CN1837205A (zh) 2006-09-27
KR100361783B1 (ko) 2002-11-22
AP2000001754A0 (en) 2000-03-31
BRPI0017522B8 (pt) 2021-05-25
CA2299495C (en) 2010-06-15
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
EA200000172A3 (ru) 2000-10-30
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
EP1031575A1 (en) 2000-08-30
TWI286142B (en) 2007-09-01
BRPI0017522A2 (ja) 2009-12-22
AU764122B2 (en) 2003-08-07
CN1137891C (zh) 2004-02-11
CA2299495A1 (en) 2000-08-26
ES2226712T3 (es) 2005-04-01
BG104175A (bg) 2000-12-29
KR100372063B1 (ko) 2003-02-14
NZ503062A (en) 2001-07-27
AR053722A2 (es) 2007-05-16
CO5160252A1 (es) 2002-05-30
AP1221A (en) 2003-11-03
KR20020065455A (ko) 2002-08-13
HU0000907D0 (en) 2000-04-28
MA25072A1 (fr) 2000-10-01
SI1031575T1 (en) 2005-02-28
UA70306C2 (en) 2004-10-15
TR200000536A2 (tr) 2000-09-21
CN1270960A (zh) 2000-10-25
JP4051314B2 (ja) 2008-02-20
DE60014212D1 (de) 2004-11-04
IN192352B (ja) 2004-04-10
ZA200000888B (en) 2001-08-23
JP2000247974A (ja) 2000-09-12
JP2003327585A (ja) 2003-11-19
US6541634B2 (en) 2003-04-01
SG90096A1 (en) 2002-07-23
KR20010006698A (ko) 2001-01-26
PE20001550A1 (es) 2001-01-11
NO20000965L (no) 2000-08-28
HK1030219A1 (en) 2001-04-27
IS5380A (is) 2000-08-27
BRPI0000967A (pt) 2001-09-11
IL134599A0 (en) 2001-04-30
SK2302000A3 (en) 2000-11-07
DZ3018A1 (fr) 2004-03-20
TNSN00035A1 (fr) 2005-11-10
IL157103A0 (en) 2004-02-08

Similar Documents

Publication Publication Date Title
DE69837264D1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
IS5276A (is) Tartrat salt af setnu dípeptíði sem vaxtarhormónsseytir
ATE370119T1 (de) Wachstumhormonsekretionsförderer
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
EE200200183A (et) Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
ATE375996T1 (de) Sekretionsfordermittel fur wachtumshormon
DE60038118D1 (de) Formulierungen von wachstumshormonen
DK1114023T3 (da) Fremgangsmåde til fremstilling af carboxylsyrer
DK1272489T3 (da) Fremgangsmåde til præparation af cabergolins krystallinske form I
DK1131083T3 (da) Anvendelse af væksthormonfrigørende forbindelser og antagonister deraf til behandling af tumorer
DK1031575T3 (da) Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
ATE339438T1 (de) Substanziell kristalline form von melagatran
PT1228056E (pt) Metodo de preparacao de citaloprame
DK1159296T3 (da) Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly)
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1399577T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer
DK1238094T3 (da) Fremgangsmåde til fremstilling af optisk aktive cyanhyhydriner under anvendelse af R-oxynitrilase
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler
DK1114174T3 (da) Fremgangsmåde til fremstilling af polycarboxylsyrer
DK1015442T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
IS4721A (is) Margbreytileg form af vaxtarhormóna seytisörvara (secretagogue)